Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension

• Egile Nagusiak: Macarena Orejudo (Egilea), Raul R. Rodrigues-Diez (Egilea), Raquel Rodrigues-Diez (Egilea), Ana Garcia-Redondo (Egilea), Laura Santos-Sánchez (Egilea), Javier Rández-Garbayo (Egilea), Pablo Cannata-Ortiz (Egilea), Adrian M. Ramos (Egilea), Alberto Ortiz (Egilea), Rafael Selgas (Egilea), Sergio Mezzano (Egilea), Carolina Lavoz (Egilea), Marta Ruiz-Ortega (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2019-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Hypertension is now considered as an inflammatory disease, and the kidney is a key end-organ target. Experimental and clinical studies suggest that interleukin 17A (IL-17A) is a promising therapeutic target in immune and chronic inflammatory diseases, including hypertension and kidney disease. Eleva...